{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:53:02Z","timestamp":1773057182619,"version":"3.50.1"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ymgmr.2020.100682","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T17:25:24Z","timestamp":1606757124000},"page":"100682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Genetic cause of heterogeneous inherited myopathies in a cohort of Greek patients"],"prefix":"10.1016","volume":"25","author":[{"given":"Ioannis","family":"Zaganas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios","family":"Mastorodemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Spilioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambros","family":"Mathioudakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Latsoudis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kleita","family":"Michaelidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Kotzamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Notas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Dimitrakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Skoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanos","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Klothaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Erimaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Vassilikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Amoiridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Efthimiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Evangeliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis","family":"Mitsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ymgmr.2020.100682_bb0005","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.0000000000000892","article-title":"Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophies","volume":"83","author":"Narayanaswami","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2017-001708","article-title":"Metabolic myopathies: a practical approach","volume":"18","author":"Lilleker","year":"2018","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0015","series-title":"Muscle Cell and Tissue - Current Status of Research Field","article-title":"Hereditary myopathies","author":"Gonz\u00e1lez-Jamett","year":"2018"},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100682_bb0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/14737175.2018.1508997","article-title":"An update on diagnostic options and considerations in limb-girdle dystrophies","volume":"18","author":"Angelini","year":"2018","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0025","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/s41436-019-0544-8","article-title":"Estimating prevalence for limb-girdle muscular dystrophy basedon public sequencing databases","volume":"21","author":"Liu","year":"2019","journal-title":"Genet. Med."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0030","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/acn3.649","article-title":"Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients","volume":"5","author":"Nallamilli","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0035","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamaneurol.2015.2274","article-title":"Use of whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy: outcomes and lessons learned","volume":"72","author":"Ghaoui","year":"2015","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100682_bb0040","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1002\/jcp.27907","article-title":"Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: A review","volume":"234","author":"Taghizadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mus.26077","article-title":"Untangling the complexity of limb-girdle muscular dystrophies","volume":"58","author":"Liewluck","year":"2018","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13023-018-0859-6","article-title":"The clinical spectrum and genetic variability of limb-girdle muscular dystrophy in a cohort of Chinese patients","volume":"13","author":"Wang","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0055","first-page":"1","article-title":"Genetic basis of limb-girdle muscular dystrophies: the 2014 update","volume":"33","author":"Nigro","year":"2014","journal-title":"Acta Myologica Myopathies Cardiomyopathies"},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0060","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: limb girdle muscular dystrophies: nomenclature and reformed classification. Naarden, the Netherlands, 19 March 2017","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100682_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.nmd.2017.06.008","article-title":"Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period","volume":"27","author":"Sframeli","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"9869","key":"10.1016\/j.ymgmr.2020.100682_bb0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","article-title":"Muscular dystrophies","volume":"381","author":"Mercuri","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13023-017-0699-9","article-title":"Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy","volume":"12","author":"Harris","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/jhg.2016.116","article-title":"The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States","volume":"62","author":"Reddy","year":"2017","journal-title":"J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40246-018-0167-1","article-title":"Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients","volume":"12","author":"Fichna","year":"2018","journal-title":"Hum. Genom."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-018-0170-1","article-title":"Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness","volume":"8","author":"Johnson","year":"2018","journal-title":"Skelet. Muscle"},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajhg.2019.01.012","article-title":"Expanding the boundaries of RNA sequencing as a diagnostic tool for rare Mendelian disease","volume":"104","author":"Gonorazky","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gim.2015.148","article-title":"Clinical application of whole-exome sequencing across clinical indications","volume":"18","author":"Retterer","year":"2016","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.ymgmr.2020.100682_bb0105","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"Kopanos","year":"2018","journal-title":"Bioinformatics"},{"issue":"D1","key":"10.1016\/j.ymgmr.2020.100682_bb0110","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13023-019-1291-2","article-title":"The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease","volume":"15","author":"Bevilacqua","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0125","series-title":"Anoctamins (TMEM16 Proteins). Functions and Involvement in Neurologic Disease","first-page":"722","volume":"89(7)","author":"Benarroch","year":"2017"},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajhg.2009.12.013","article-title":"Recessive mutations in the putative calcium-activated chloride channel anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies","volume":"86","author":"Bolduc","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nmd.2015.03.011","article-title":"Next generation sequencing on patients with LGMD and nonspecific myopathies: findings associated with ANO5 mutations","volume":"25","author":"Savarese","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/brain\/awq294","article-title":"A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy","volume":"134","author":"Hicks","year":"2010","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0145","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/humu.22342","article-title":"ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation","volume":"34","author":"Sarkozy","year":"2013","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0150","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0b013e31824c4682","article-title":"Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5","volume":"78","author":"Penttil\u00e4","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2020.100682_bb0155","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.nmd.2012.05.012","article-title":"Muscle MRI findings in limb girdle muscular dystrophy type 2L","volume":"22","author":"Sarkozy","year":"2012","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2012.09.070","article-title":"Dilated cardiomyopathy in patients with mutations in anoctamin 5","volume":"168","author":"Wahbi","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100682_bb0165","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nmd.2011.06.872","article-title":"P2.50 LGMD2L in Italian population: New mutations and clinical and morphological aspects","volume":"21","author":"Magri","year":"2011","journal-title":"Neuromuscul. Disord."},{"issue":"23","key":"10.1016\/j.ymgmr.2020.100682_bb0170","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMra043361","article-title":"Calpains and disease","volume":"352","author":"Zatz","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0175","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/brain\/aww133","article-title":"A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy","volume":"139","author":"Vissing","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0180","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.25970","article-title":"Autosomal dominant calpainopathy due to heterozygous CAPN3 C.643_663del21","volume":"57","author":"Martinez-Thompson","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgmr.2020.100682_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biochi.2015.09.010","article-title":"An eccentric calpain, CAPN3\/p94\/calpain-3","volume":"122","author":"Ono","year":"2016","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0190","first-page":"1128","article-title":"Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins","volume":"60","author":"Richard","year":"1997","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00431-005-0046-3","article-title":"Calpain-3 mutations in Turkey","volume":"165","author":"Balci","year":"2006","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0200","first-page":"657","article-title":"Calpainopathy (LGMD2A) in Croatia: molecular and haplotype analysis","volume":"46","author":"Milic","year":"2005","journal-title":"Croat. Med. J."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10048-007-0083-3","article-title":"A large deletion and novel point mutations in the calpain 3 gene (CAPN3) in Bulgarian LGMD2A patients","volume":"8","author":"Todorova","year":"2007","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/NRL.0000000000000036","article-title":"Caveolinopathies in Greece","volume":"20","author":"Papadopoulos","year":"2015","journal-title":"Neurologist"},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0215","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.nmd.2016.05.006","article-title":"CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: expanding the phenotypic spectrum of caveolinopathies","volume":"26","author":"Scalco","year":"2016","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ejhg.2009.103","article-title":"Caveolinopathies: from the biology of caveolin-3 to human diseases","volume":"18","author":"Gazzerro","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"issue":"20","key":"10.1016\/j.ymgmr.2020.100682_bb0225","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.106.635268","article-title":"Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome","volume":"114","author":"Vatta","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100682_bb0230","first-page":"1104","article-title":"Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data","volume":"29","author":"Andreasen","year":"2013","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hrthm.2006.11.030","article-title":"Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3","volume":"4","author":"Cronk","year":"2007","journal-title":"Heart Rhythm."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0240","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.nmd.2013.08.003","article-title":"\u2018Double trouble\u2019: diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia","volume":"23","author":"Donkervoort","year":"2013","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0245","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/CIRCGENETICS.113.000137","article-title":"The role of CAV3 in long QT syndrome","volume":"6","author":"Hedley","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0250","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ejhg.2012.23","article-title":"High prevalence of genetic variants previously associated with LQT syndrome in new exome data","volume":"20","author":"Refsgaard","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100682_bb0255","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.nmd.2011.12.001","article-title":"Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: further evidence for \u201cdouble trouble\u201d overlapping syndromes","volume":"22","author":"Ricci","year":"2012","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/humu.22460","article-title":"Exome sequencing identifies potential risk variants for Mendelian disorders at high prevalence in Qatar","volume":"35","author":"Rodriguez-Flores","year":"2014","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/labinvest.3700713","article-title":"Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro","volume":"88","author":"Traverso","year":"2008","journal-title":"Lab. Investig."},{"issue":"24","key":"10.1016\/j.ymgmr.2020.100682_bb0270","doi-asserted-by":"crossref","first-page":"17472","DOI":"10.1074\/jbc.M112.435370","article-title":"The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long QT syndrome 9 (LQT9)","volume":"288","author":"Vaidyanathan","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0275","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.nmd.2012.03.007","article-title":"CAV3 T78M mutation as polymorphic variant in South Italy","volume":"22","author":"Spadafora","year":"2012","journal-title":"Neuromuscul. Disord."},{"issue":"37","key":"10.1016\/j.ymgmr.2020.100682_bb0280","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/eurheartj\/ehv297","article-title":"Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval","volume":"36","author":"Ghouse","year":"2015","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ymgmr.2020.100682_bb0285","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cvr\/cvx122","article-title":"The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability","volume":"113","author":"Campostrini","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/awp294","article-title":"The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment","volume":"133","author":"Matthews","year":"2009","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0295","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mus.23683","article-title":"The diagnosis and treatment of myotonic disorders","volume":"47","author":"Heatwole","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgmr.2020.100682_bb0300","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.26887","article-title":"Guidelines on clinical presentation and management of non-dystrophic myotonias","volume":"62","author":"Stunnenberg","year":"2020","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.ymgmr.2020.100682_bb0305","first-page":"2071","article-title":"Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita","volume":"3","author":"George","year":"1994","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100682_bb0310","first-page":"1325","article-title":"Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia","volume":"57","author":"Meyer-Kleine","year":"1995","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.ymgmr.2020.100682_bb0315","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nmd.2016.08.001","article-title":"Myotonia congenita type Becker in Bulgaria: first genetically proven cases and mutation screening of two presumable endemic regions","volume":"26","author":"Tincheva","year":"2016","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0320","first-page":"669","article-title":"Clinical evaluation and cellular electrophysiology of a recessive CLCN1 patient","volume":"64","author":"Lucchiari","year":"2013","journal-title":"J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0325","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.22916","article-title":"Identification and functional characterization of CLCN1 mutations found in nondystrophic myotonia patients","volume":"37","author":"Vindas-Smith","year":"2016","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.ymgmr.2020.100682_bb0330","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/01.LAB.0000098428.51765.83","article-title":"Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review","volume":"83","author":"Sigauke","year":"2003","journal-title":"Lab. Investig."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s10038-018-0530-z","article-title":"Carnitine palmitoyltransferase II deficiency with a focus on newborn screening","volume":"64","author":"Tajima","year":"2019","journal-title":"J. Hum. Genet."},{"issue":"15","key":"10.1016\/j.ymgmr.2020.100682_bb0340","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s00018-009-0035-1","article-title":"Structural insight into function and regulation of carnitine palmitoyltransferase","volume":"66","author":"Rufer","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0345","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-0004.2011.01786.x","article-title":"Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency","volume":"82","author":"Fanin","year":"2012","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0350","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ng0793-314","article-title":"Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients","volume":"4","author":"Taroni","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0355","first-page":"69","article-title":"Recurrent rhabdomyolysis caused by carnitine palmitoyltransferase II deficiency, common but under-recognised: Lessons to be learnt","volume":"15","author":"Balasubramanian","year":"2018","journal-title":"Mol. Genet. Metabol. Rep."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0360","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00467-017-3755-8","article-title":"Exome sequencing in Jewish and Arab patients with rhabdomyolysis reveals single-gene etiology in 43% of cases","volume":"32","author":"Vivante","year":"2017","journal-title":"Pediatr. Nephrol."},{"issue":"23","key":"10.1016\/j.ymgmr.2020.100682_bb0365","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00508-012-0296-9","article-title":"Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency","volume":"124","author":"Joshi","year":"2012","journal-title":"Wien. Klin. Wochenschr."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0370","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjms.2016.05.024","article-title":"Limb-girdle muscular dystrophy 2B and miyoshi presentations of dysferlinopathy","volume":"353","author":"Patel","year":"2017","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100682_bb0375","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ejhg.2011.70","article-title":"Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations","volume":"19","author":"Cacciottolo","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0380","series-title":"Handbook of Clinical Neurology","first-page":"111","article-title":"Chapter 7 - dysferlinopathies","author":"Amato","year":"2011"},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0385","doi-asserted-by":"crossref","first-page":"e29061","DOI":"10.1371\/journal.pone.0029061","article-title":"Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy","volume":"6","author":"Gallardo","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0390","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.9355","article-title":"Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies","volume":"26","author":"Nguyen","year":"2005","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0395","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneur.64.8.1176","article-title":"Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes","volume":"64","author":"Nguyen","year":"2007","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0400","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nmd.2008.09.015","article-title":"A new phenotype of dysferlinopathy with congenital onset","volume":"19","author":"Paradas","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0405","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3233\/JND-140038","article-title":"Whole exome sequencing reveals DYSF, FKTN, and ISPD mutations in congenital muscular dystrophy without brain or eye involvement","volume":"2","author":"Ceyhan-Birsoy","year":"2015","journal-title":"J. Neuromusc. Dis."},{"issue":"11","key":"10.1016\/j.ymgmr.2020.100682_bb0410","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.nmd.2007.07.010","article-title":"Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene","volume":"17","author":"Leshinsky-Silver","year":"2007","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0415","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1212\/WNL.0000000000005867","article-title":"Pearls and Oy-sters: a curable myopathy manifesting as exercise intolerance and respiratory failure","volume":"91","author":"Silva","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0420","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","article-title":"The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene","volume":"130","author":"Gempel","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymgmr.2020.100682_bb0425","series-title":"JIMD Reports - Case and Research Reports","first-page":"1","article-title":"Newborn screening for glutaric aciduria-II: the New England experience","volume":"13","author":"Sahai","year":"2014"},{"issue":"15","key":"10.1016\/j.ymgmr.2020.100682_bb0430","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/hmg\/dds175","article-title":"Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency","volume":"21","author":"Cornelius","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0435","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymgmr.2020.100682_bb0440","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2017.11.012","article-title":"A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency","volume":"384","author":"van der Westhuizen","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0445","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2008.01.002","article-title":"Clinical and molecular investigations of Japanese cases of glutaric acidemia type 2","volume":"94","author":"Yotsumoto","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000334398","article-title":"Late onset glycogen storage disease type II: pitfalls in the diagnosis","volume":"67","author":"Papadimas","year":"2012","journal-title":"Eur. Neurol."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0455","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nmd.2017.12.001","article-title":"Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy","volume":"28","author":"Golsari","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0460","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13023-017-0722-1","article-title":"Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness","volume":"12","author":"Johnson","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0465","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2017.10.008","article-title":"Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease","volume":"122","author":"Mori","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgmr.2020.100682_bb0470","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3390\/ijms17101735","article-title":"Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe disease","volume":"17","author":"Boentert","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0475","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","article-title":"Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (\u2013 13T\u2192G) mutation in a majority of patients and a novel IVS10 (+ 1GT \u2192 CT) mutation","volume":"3","author":"Hule","year":"1994","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0480","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2007.05.011","article-title":"Glycogen storage disease type II in Spanish patients: high frequency of c.1076-1G>C mutation","volume":"92","author":"Gort","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0485","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nmd.2015.04.008","article-title":"Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: a Spanish cohort","volume":"25","author":"Guti\u00e9rrez-Rivas","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0490","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00415-017-8686-6","article-title":"Pompe disease in Austria: clinical, genetic and epidemiological aspects","volume":"265","author":"L\u00f6scher","year":"2018","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0495","first-page":"887","article-title":"Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II","volume":"56","author":"Boerkoel","year":"1995","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0500","doi-asserted-by":"crossref","first-page":"46","DOI":"10.33588\/rn.2901.99082","article-title":"Severe form of juvenile type II glycogenosis in a compound-heterozygous boy (Tyr-292--> Cys\/Arg-854-->Stop)","volume":"29","author":"Castro-Gago","year":"1999","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0505","series-title":"JIMD Reports","first-page":"71","article-title":"Hypertrophic cardiomyopathy in pompe disease is not limited to the classic infantile-onset phenotype","volume":"17","author":"Lee","year":"2014"},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0510","first-page":"311","article-title":"Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients","volume":"43","author":"Park","year":"2013","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0515","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/humu.10286","article-title":"Twenty-two novel mutations in the lysosomal \u03b1-glucosidase gene (GAA) underscore the genotype\u2013phenotype correlation in glycogen storage disease type II","volume":"23","author":"Hermans","year":"2004","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0520","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/humu.21121","article-title":"The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase","volume":"30","author":"Flanagan","year":"2009","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0525","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/aws312","article-title":"ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies","volume":"136","author":"Cirak","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0530","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng.2252","article-title":"ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome","volume":"44","author":"Willer","year":"2012","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.ymgmr.2020.100682_bb0535","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0b013e3182840cbc","article-title":"Limb-girdle muscular dystrophy with \u03b1-dystroglycan deficiency and mutations in the <em>ISPD<\/em> gene","volume":"80","author":"Tasca","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0540","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nmd.2014.08.007","article-title":"A novel homozygous ISPD gene mutation causing phenotype variability in a consanguineous family","volume":"25","author":"Baranello","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0545","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ng.2253","article-title":"Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of \u03b1-dystroglycan","volume":"44","author":"Roscioli","year":"2012","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0550","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12883-015-0428-8","article-title":"ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases","volume":"15","author":"Magri","year":"2015","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0555","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/jcmm.14218","article-title":"A molecular overview of the primary dystroglycanopathies","volume":"23","author":"Brancaccio","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100682_bb0560","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ajhg.2012.10.009","article-title":"Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly","volume":"91","author":"Vuillaumier-Barrot","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.ymgmr.2020.100682_bb0565","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/humu.23599","article-title":"LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-\u03b12 variome and its related phenotypes","volume":"39","author":"Oliveira","year":"2018","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0570","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.410420110","article-title":"Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities","volume":"42","author":"van der Knaap","year":"1997","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0575","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5483\/BMBRep.2018.51.7.113","article-title":"Laminopathies; mutations on single gene and various human genetic diseases","volume":"51","author":"Kang","year":"2018","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/fn.2016.58910","article-title":"Emery-Dreifuss muscular dystrophy: the most recognizable laminopathy","volume":"54","author":"Madej-Pilarczyk","year":"2016","journal-title":"Folia Neuropathol."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0585","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M18-2768","article-title":"Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy","volume":"171","author":"Peretto","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100682_bb0590","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/heartjnl-2017-312338","article-title":"Lamin and the heart","volume":"104","author":"Captur","year":"2018","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0595","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13023-019-1245-8","article-title":"Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset","volume":"14","author":"Ditaranto","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0600","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/19491034.2016.1260798","article-title":"Current insights into LMNA cardiomyopathies: existing models and missing LINCs","volume":"8","author":"Brayson","year":"2017","journal-title":"Nucleus"},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0605","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/302869","article-title":"Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy","volume":"66","author":"Raffaele di Barletta","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0610","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1111\/j.1747-0803.2012.00695.x","article-title":"Hypoplasia of the aorta in a patient diagnosed with LMNA gene mutation","volume":"8","author":"Coutance","year":"2013","journal-title":"Congenit. Heart Dis."},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0615","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bbadis.2009.05.007","article-title":"Defects in cell spreading and ERK1\/2 activation in fibroblasts with lamin A\/C mutations","volume":"1792","author":"Emerson","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0620","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s100380200029","article-title":"Identification of lamin A\/C (LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B","volume":"47","author":"Ki","year":"2002","journal-title":"J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0625","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2011.04.010","article-title":"Inflammatory changes in infantile-onset LMNA-associated myopathy","volume":"21","author":"Komaki","year":"2011","journal-title":"Neuromuscul. Disord."},{"issue":"22","key":"10.1016\/j.ymgmr.2020.100682_bb0630","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1242\/jcs.072157","article-title":"Specific phosphorylation of Ser458 of A-type lamins in LMNA-associated myopathy patients","volume":"123","author":"Mitsuhashi","year":"2010","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0635","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cge.12826","article-title":"Discovery of pathogenic variants in a large Korean cohort of inherited muscular disorders","volume":"91","author":"Park","year":"2017","journal-title":"Clin. Genet."},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100682_bb0640","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/hmg\/9.9.1453","article-title":"Identification of mutations in the gene encoding lamins A\/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)","volume":"9","author":"Muchir","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0645","first-page":"1017","article-title":"Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus","volume":"56","author":"Hao","year":"1995","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0650","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jns.2004.10.018","article-title":"Congenital or late-onset myopathy in patients with the T14709C mtDNA mutation","volume":"228","author":"Mancuso","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0655","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/JPEM.1999.12.2.207","article-title":"Early onset of diabetes mellitus associated with the mitochondrial DNA T14709C point mutation: patient report and literature review","volume":"12","author":"Damore","year":"1999","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0660","first-page":"1026","article-title":"Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation","volume":"56","author":"Hanna","year":"1995","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0665","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20004","article-title":"Familial myopathy: new insights into the T14709C mitochondrial tRNA mutation","volume":"55","author":"McFarland","year":"2004","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.ymgmr.2020.100682_bb0670","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2337\/diacare.20.11.1731","article-title":"Phenotypic expression of diabetes secondary to a T14709C mutation of mitochondrial DNA. Comparison with MIDD syndrome (A3243G mutation): a case report","volume":"20","author":"Vialettes","year":"1997","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0675","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1464-5491.2001.00429-2.x","article-title":"Association of the T14709C mutation of mitochondrial DNA with maternally inherited diabetes mellitus and\/or deafness in an Italian family","volume":"18","author":"Rigoli","year":"2001","journal-title":"Diabet. Med."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100682_bb0680","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0685","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/NEN.0b013e318244477d","article-title":"Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study","volume":"71","author":"Lax","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100682_bb0690","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/aws110","article-title":"Microangiopathy in the cerebellum of patients with mitochondrial DNA disease","volume":"135","author":"Lax","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0695","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jdiacomp.2009.11.002","article-title":"The heteroplasmic m.14709T>C mutation in the tRNAGlu gene in two Tunisian families with mitochondrial diabetes","volume":"24","author":"Mezghani","year":"2010","journal-title":"J. Diabetes Complicat."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0700","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0925-4439(02)00167-9","article-title":"Molecular and functional effects of the T14709C point mutation in the mitochondrial DNA of a patient with maternally inherited diabetes and deafness","volume":"1588","author":"Perucca-Lostanlen","year":"2002","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100682_bb0705","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s13353-018-0463-4","article-title":"Myofibrillar myopathy in the genomic context","volume":"59","author":"Fichna","year":"2018","journal-title":"J. Appl. Genet."},{"issue":"10","key":"10.1016\/j.ymgmr.2020.100682_bb0710","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/brain\/awh576","article-title":"Myotilinopathy: refining the clinical and myopathological phenotype","volume":"128","author":"Oliv\u00e9","year":"2005","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0715","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/01.WNL.0000123576.74801.75","article-title":"Mutations in myotilin cause myofibrillar myopathy","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ymgmr.2020.100682_bb0720","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.nmd.2008.06.367","article-title":"Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene","volume":"18","author":"Claeys","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100682_bb0725","doi-asserted-by":"crossref","first-page":"E138","DOI":"10.1002\/mus.26078","article-title":"Myotilinopathy unmasked by statin treatment: a case report","volume":"57","author":"Ramos-Fransi","year":"2018","journal-title":"Muscle Nerve"},{"issue":"14","key":"10.1016\/j.ymgmr.2020.100682_bb0730","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/hmg\/9.14.2141","article-title":"Myotilin is mutated in limb girdle muscular dystrophy 1A","volume":"9","author":"Hauser","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0735","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-020-1296-x","article-title":"Mutational spectrum of autosomal recessive limb-girdle muscular dystrophies in a cohort of 112 Iranian patients and reporting of a possible founder effect","volume":"15","author":"Mojbafan","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2020.100682_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134833","article-title":"The role of the dystrophin glycoprotein complex on the neuromuscular system","volume":"722","author":"Belhasan","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0745","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1002\/jcp.25982","article-title":"ABC of multifaceted dystrophin glycoprotein complex (DGC)","volume":"233","author":"Bhat","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0750","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nyas.13500","article-title":"The molecular cross talk of the dystrophin\u2013glycoprotein complex","volume":"1412","author":"Gawor","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"14","key":"10.1016\/j.ymgmr.2020.100682_bb0755","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1093\/hmg\/ddu088","article-title":"Unveiling the degradative route of the V247M \u03b1-sarcoglycan mutant responsible for LGMD-2D","volume":"23","author":"Bianchini","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.ymgmr.2020.100682_bb0760","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.nmd.2015.09.010","article-title":"Alpha-sarcoglycanopathy presenting as exercise intolerance and rhabdomyolysis in two adults","volume":"25","author":"Tarnopolsky","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0765","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ng0695-243","article-title":"Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity","volume":"10","author":"Piccolo","year":"1995","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100682_bb0770","first-page":"1","article-title":"Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood","volume":"23","author":"Walter","year":"2004","journal-title":"Acta Myol."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0775","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/humu.21659","article-title":"Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications","volume":"33","author":"Soheili","year":"2012","journal-title":"Hum. Mutat."},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100682_bb0780","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM199702273360904","article-title":"Mutations in the sarcoglycan genes in patients with myopathy","volume":"336","author":"Duggan","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"02","key":"10.1016\/j.ymgmr.2020.100682_bb0785","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2002-32374","article-title":"Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuria","volume":"33","author":"Mongini","year":"2002","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100682_bb0790","first-page":"115","article-title":"Alpha vs. gamma sarcoglycanopathy: DNA tests solve a case from Argentina","volume":"26","author":"Avila De Salman","year":"2007","journal-title":"Acta Myologica Myopathies Cardiomyopathies"},{"key":"10.1016\/j.ymgmr.2020.100682_bb0795","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2018.08.026","article-title":"Milder forms of \u03b1-sarcoglicanopathies diagnosed in adulthood by NGS analysis","volume":"394","author":"Cantero","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100682_bb0800","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/cjn.2017.286","article-title":"Next-generation sequencing to diagnose muscular dystrophy, rhabdomyolysis, and HyperCKemia","volume":"45","author":"Wu","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.ymgmr.2020.100682_bb0805","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/hum.2019.006","article-title":"Gene delivery for limb-girdle muscular dystrophy type 2D by isolated limb infusion","volume":"30","author":"Mendell","year":"2019","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:56Z","timestamp":1762001636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426920301282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":161,"alternative-id":["S2214426920301282"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100682","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic cause of heterogeneous inherited myopathies in a cohort of Greek patients","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100682"}}